Consistent with the literature and the many roles of PLK1 in the initiation, progression and completion of mitosis, treatment of HT29 tumor cells with onvansertib led to stabilization of mitotic markers (Supplementary Figure 1D) associated with an increased G2/M population by flow cytometry analysis (Supplementary Figure 1F). The gene discussed is PLK1; the disease is neoplasm.